Phaarmasia Peer Comparison

BSE: 523620

₹82.65

₹-4.35 (-5.00%)

As on 22-Sep-2026 12:09IST

Market cap

₹59 Cr

Revenue (TTM)

₹49 Cr

P/E Ratio

3.4

P/B Ratio

2.6

Div. Yield

0 %

Edit

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	59	21,460	20,797	17,919	18,493
Revenue (₹ Cr)	49	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	17.65	678.07	273.51	666.92	735.15
Net Margin (%)	35.60	28.10	16.19	20.60	26.88
RoE (%)	12.94	19.73	11.15	18.75	19.16
Price to Earnings	3.37	32.25	69.95	27.83	25.16
Price-To-Book	2.65	5.84	7.74	4.44	4.20

Income Statement (₹ Cr)

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	48.62	2,287.33	1,682.47	3,229.67	2,569.77
Total Income	49.57	2,413.29	1,689.83	3,237.12	2,735.39
Total Expenditure	46.78	1,490.75	1,203.91	2,090.06	1,628.14
EBITDA	1.83	796.58	478.55	1,139.61	941.63
Depreciation	0.19	78.10	126.01	281.06	57.58
EBIT	1.64	718.48	352.55	858.55	884.05
Interest	0.21	0.88	52.11	190.64	7.69
Other Income	0.95	125.96	7.37	7.45	165.62
Exceptional Items	19.00	0.00	12.16	-17.24	-49.16
Profit before Tax	21.38	843.56	319.96	658.12	992.82
Provision for Tax	3.74	165.49	46.45	-8.80	257.67
Profit after Tax	17.65	678.07	273.51	666.92	735.15

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	22.10	3,586.42	2,591.20	3,902.67	4,202.90
Minority Interest	0.00	-12.71	0.00	-21.81	0.00
Non-Current Liabilities	1.37	28.74	266.35	1,392.75	91.50
Current Liabilities	6.60	385.94	848.06	2,077.10	627.48
Total Liabilities	21.68	3,207.85	3,310.68	6,865.52	4,911.11

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	1.06	1,291.22	2,525.44	5,617.77	770.28
Current Assets	26.74	2,585.66	1,109.77	1,539.85	3,803.22
Total Assets	21.68	3,207.85	3,310.68	6,865.52	4,911.11
Total Debt*	0.00	0.55	586.37	2,421.66	2.50
Net Current Assets	20.14	2,199.72	261.71	-537.25	3,175.74
Contingent Liabilities	0.16	0.64	76.22	51.96	363.79

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	0.00	432.37	132.27	1,065.01	659.75
Cash Flow from Investing Activities	-0.12	-334.73	-199.13	-79.97	-71.34
Cash from Financing Activities	-0.15	-38.32	62.65	-881.32	-205.34
Net Cash Inflow / Outflow	-0.27	59.32	-4.21	103.72	383.07

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	-30.07	26.22	6.95	13.59	26.21
ROE (%)	12.94	19.73	11.15	18.75	19.16
ROA (%)	68.36	18.69	7.80	9.26	14.95
EBIT Margin (%)	3.38	31.41	20.95	26.58	34.40
Net Margin (%)	35.60	28.10	16.19	20.60	26.88
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	111.83	15.01	27.91	9.59	10.69
EBIT Growth (%)	168.06	18.45	58.32	16.84	24.14
Net Profit Growth (%)	1,204.88	19.61	149.56	62.68	-9.09
EPS Growth (%)	233.03	17.73	-3.57	67.41	14.40
Book Value Growth (%)	-25.79	23.77	30.63	10.19	17.30

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	27.96	31.50	74.73	27.20	23.95
Price / Book Value	2.65	5.71	7.80	4.45	4.19
Dividend Yield (%)	0.00	0.29	0.06	0.00	1.86
EV/EBITDA	32.20	25.04	45.05	17.72	16.32
Market Cap (₹ Cr)	20.01	15,219.80	6,484.12	19,292.77	18,318.10

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	0.05	0.00	0.07	0.24	0.00
Short term debt to equity ratio	--	0.00	0.13	0.14	0.00
Current Ratio	4.05	6.70	1.31	0.74	6.06
Quick Ratio	3.39	5.59	0.88	0.53	5.31
Interest Coverage	105.30	959.59	7.14	4.45	130.11

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	10.56	36.10	30.84	21.07	7.07
Asset Turnover	1.88	0.63	0.48	0.45	0.52
Receivable days	83.55	110.70	118.15	54.06	29.10
Inventory Days	86.55	65.86	98.29	32.16	69.53
Payable days	406.82	105.88	128.16	140.91	76.77
Cash Conversion Cycle	-236.72	70.68	88.28	-54.69	21.86

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.